CN1085662C - 制备氯甲基吡啶类化合物的方法 - Google Patents

制备氯甲基吡啶类化合物的方法 Download PDF

Info

Publication number
CN1085662C
CN1085662C CN94108119A CN94108119A CN1085662C CN 1085662 C CN1085662 C CN 1085662C CN 94108119 A CN94108119 A CN 94108119A CN 94108119 A CN94108119 A CN 94108119A CN 1085662 C CN1085662 C CN 1085662C
Authority
CN
China
Prior art keywords
under
temperature
formula
chloro
aminomethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN94108119A
Other languages
English (en)
Other versions
CN1098405A (zh
Inventor
H·克劳斯
H·林德尔
H·-J·迪尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of CN1098405A publication Critical patent/CN1098405A/zh
Application granted granted Critical
Publication of CN1085662C publication Critical patent/CN1085662C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26Radicals substituted by halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals

Abstract

本发明涉及制备通式(I)的氯甲基吡啶类化合物(其中n代表数字0、1、2或3,和×代表卤素)的一种新方法,即将通式(II)的氨甲基吡啶类化合物与亚硝基化剂或重氮化剂在稀释剂存在下及任选在氯化氢的存在下,在温度为-20℃至+50℃之间进行反应,然后按照常规方法进行处理。

Description

制备氯甲基吡啶类化合物的方法
本发明涉及制备氯甲基吡啶类化合物的一种新方法。
已知氯甲基吡啶类化合物可由羟甲基吡啶类化合物与亚硫酰氯反应制得(参见J.Heterocycl. Chem.16(1979),333-337;也可参见EP-A 373464)。
还已知氯甲基吡啶类化合物也可通过在酸性接受体或自由基形成体存在下并在惰性稀释剂存在下,在0℃至100℃之间的温度下,氯化甲基吡啶类化合物而制得(参见EP-A 260485,也可参见EP-A458109)。
此外,已知烷氧基甲基吡啶类化合物通过与合适的氯化剂反应也可被转化成氯甲基吡啶类化合物(参见EP-A 393453)。
现已发现通式(I)的氯甲基吡啶类化合物,
Figure C9410811900031
其中:n代表数字0、1、2或3;和
X代表卤素;可通过将通式(II)的氨甲基吡啶类化合物
Figure C9410811900041
其中:n具有上面所给出的定义;和
X代表氨基或卤素;与亚硝基化剂或重氮化剂在稀释剂和任选在氯化氢存在下,在温度为-20℃到+50℃之间进行反应,然后按常规方法处理而以高产率制得。
令人吃惊的是,通式(I)的氯甲基吡啶类化合物按照本发明方法可以高产率制得。
本发明方法优选涉及制备式(I)化合物(其中n代表数字0、1或2,及X代表氟、氯或溴)。
具体地讲,本发明方法涉及制备3-氯甲基吡啶、2-氯-5-氯甲基吡啶和2,3-二氯-5-氯甲基吡啶。
例如,若用3-氨甲基吡啶和亚硝酰氯作起始物质,则本发明方法的反应路线可用下面的反应路线中的反应式来表示:
Figure C9410811900042
在本发明方法中用作起始物质的氨甲基吡啶类化合物一般由式(II)所定义。在式(II)中,n优选具有在将要按本发明方法制备的式(I)化合物的描述中所给出的n的优选意义,而X优选代表氨基、氟、氯或溴。
可提及的式(II)起始物质的实例有:3-氨甲基吡啶、2-氯-5-氨甲基吡啶、2-氨基-5-氨甲基吡啶和2,3-二氯-5-氨甲基吡啶。
式(II)起始物质是已知的和/或可按照本身已知的方法制备的(参见DEOS(德国公开说明书)3726993和WO 92/13840)。
用于制备式(I)的氯甲基吡啶类化合物的本发明方法是通过使用亚硝基化剂或重氮化剂进行的。适合的亚硝基化剂或重氮化剂特别是含有能容易地以亚硝酰基团(NO)断裂的组分的化合物。这些化合物优选包括亚硝酰氯、亚硝基硫酸和三氧化二氮以及亚硝酸烷基酯如亚硝酸甲酯、亚硝酸乙酯、亚硝酸丙酯和亚硝酸丁酯。亚硝酰氯特别优选用作本发明方法中的亚硝基化剂/重氮化剂。
本发明方法是在稀释剂存在下进行的。合适的稀释剂为常用的有机溶剂,例如(任选氯化)烃类如戊烷、己烷、庚烷、辛烷、环己烷、甲基环己烷、石油醚、汽油、轻石油、二氯甲烷、二氯乙烷、氯仿、四氯化碳、氯苯和邻二氯苯;醚类如乙醚、二丙醚、二异丙醚、二丁醚、二异丁醚、甲基叔丁基醚、甲基叔戊基醚、乙二醇二甲醚、四氢呋喃和二烷;酮类如丙酮、二乙基酮、甲基异丙基酮和甲基异丁基酮;酯类如乙酸甲酯和乙酸乙酯;腈类如乙腈和丙腈;酰胺类如N,N-二甲基甲酰胺、N,N-二乙基甲酰胺、N,N-二丙基甲酰胺、N,N-二丁基甲酰胺、N,N-二环己基甲酰胺和N,N-二甲基乙酰胺;其它如N-甲基吡咯烷酮、四甲基脲、二甲亚砜、四氢噻吩砜、液态二氧化硫和水。
水和上述有机溶剂(条件是它们实际上与水不混溶)的两相体系也可用作稀释剂,在此情况中优选使用相转移催化剂。可提及的这类催化剂的实例为:溴化四丁基铵、氯化四丁基铵、氯化四辛基铵、硫酸氢四丁基铵、氯化甲基三辛基铵、氯化十六烷基三甲基铵、溴化十六烷基三甲基铵、氯化苄基三甲基铵、氯化苄基三乙基铵、氢氧化苄基三甲基铵、氢氧化苄基三乙基铵、氯化苄基三丁基铵、溴化苄基三丁基铵、溴化四丁基鏻、氯化四丁基鏻、溴化三丁基十六烷基鏻,氯化丁基三苯基鏻、溴化乙基三辛基鏻、溴化四苯基鏻。
在本发明方法中反应温度可在较宽范围内变化。本方法一般在温度为-20℃至+50℃之间,优选为-10℃到+40℃之间进行。
本发明方法一般在大气压下或在略微加压或略微减压下,通常在1×104帕(0.1巴)到1×106帕(10巴)之间进行。
本发明方法一般在对于每1摩尔式(II)的氨甲基吡啶使用1到5摩尔,优选2到3摩尔的亚硝基化剂或重氮化剂的条件下进行。
在本发明方法优选的实施方案中,先将式(II)的氨甲基吡啶加入到一种上述稀释剂中,并在搅拌的同时加入规定量的亚硝基化剂或重氮化剂在一种上述稀释剂中的溶液。然后搅拌反应混合物直到反应结束;然后按常规方法处理所述混合物。
在本发明另一优选的实施方案中,先将亚硝基化剂或重氮化剂加入到一种上述稀释剂中,任选在氯化氢存在下,在搅拌的同时加入规定量的式(II)的氨甲基吡啶在一种上述稀释剂中的溶液。然后搅拌反应混合物直到反应结束;然后按常规方法处理所述混合物。
后处理可按常规方法进行。例如,反应混合物(任选在浓缩后)用水稀释,然后用氢氧化钠溶液或碳酸(氢)钠中和,有机相任选用与水实际上不混溶的有机溶剂(例如二氯甲烷)稀释。摇动后,把有机相分离出来,干燥并过滤。然后在减压下将有机溶剂从滤液中小心地蒸馏除去。所得到的式(I)的产品为油状残余物,它可用常规方法进一步纯化。
可按照本发明方法制备的式(I)的氯甲基吡啶类化合物可用作制备生物活性化合物如杀虫剂的中间体(参见EP-A 163855和EP-A192060)。
                          实例1
在10℃下在约90分钟内并在搅拌下将9.2克(141毫摩尔)亚硝酰氯的50毫升二氯甲烷溶液逐滴加入到10.0克(70毫摩尔)2-氯-5-氨甲基吡啶的200毫升二氯甲烷溶液中。然后在20℃将反应混合物进一步搅拌2小时。然后加入100毫升水并通过加入碳酸氢钠调节pH至7。把有机相分离出来,并且水相用二氯甲烷进一步萃取两次以上,每次用50ml。然后将溶剂在用水泵抽真空条件下从合并的有机相中小心蒸馏除去。
根据气相色谱法分析,所剩残余物含有6.8克(为理论量的60%)2-氯-5-氯甲基吡啶和3.5克(为理论量的35%)2-氯-5-羟甲基吡啶。
作为副产品得到的2-氯-5-羟甲基吡啶可以用常规方法分离出来并用已知方法(参见EP-A 373464)转变为2-氯-5-氯甲基吡啶。
                          实施例2
Figure C9410811900081
将25毫升N,N-二甲基甲酰胺在20℃时用氯化氢饱和。进一步用200毫升N,N-二甲基甲酰胺稀释此溶液,并在冷却至-10℃后,加入20毫升经预冷却的亚硝酰氯。使混合物的温度达到0℃。并在此温度下逐滴加入17.3克(122毫摩尔)2-氨基-5-氨甲基吡啶的100毫升N,N-二甲基甲酰胺溶液。然后使反应混合物的温度达到室温(20℃),并在此温度下进一步搅拌1小时。然后在用水泵抽真空条件下将反应混合物浓缩,并通过加入50毫升0.2N氢氧化钠水溶液进行中和,并与150毫升二氯甲烷一起振摇。分离出有机相,用硫酸钠干燥后过滤。溶剂在用水泵抽真空的条件下从滤液中小心蒸馏除去。
根据1H-NMR谱分析,得到的14克油状物含有85%的2-氯-5-氯甲基吡啶(为理论量的60%)。

Claims (4)

1.制备通式(I)的氯甲基吡啶的方法
Figure C9410811900021
其中,X表示卤素,其特征在于通式(II)的氨基甲基吡啶
Figure C9410811900022
其中,X表示氨基或卤素与亚硝酰氯在有机稀释剂存在时在-20℃至+50℃温度下反应。
2.制备下面式子的2-氯-5-氯甲基吡啶的方法
Figure C9410811900023
其特征在于下面式子的2-氯-5-氨基甲基吡啶与亚硝酰氯在有机稀释剂存在时在-10℃至+40℃温度下反应。
3.根据权利要求2的方法,其特征在于反应在二氯甲烷中在+10℃至+20℃温度下进行。
4.根据权利要求2的方法,其特征在于反应在二甲基甲酰胺中在-10℃至+20℃温度下进行。
CN94108119A 1993-07-02 1994-07-02 制备氯甲基吡啶类化合物的方法 Expired - Fee Related CN1085662C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP4322054.1 1993-07-02
DE4322054A DE4322054A1 (de) 1993-07-02 1993-07-02 Verfahren zur Herstellung von Chlormethylpyridinen

Publications (2)

Publication Number Publication Date
CN1098405A CN1098405A (zh) 1995-02-08
CN1085662C true CN1085662C (zh) 2002-05-29

Family

ID=6491797

Family Applications (1)

Application Number Title Priority Date Filing Date
CN94108119A Expired - Fee Related CN1085662C (zh) 1993-07-02 1994-07-02 制备氯甲基吡啶类化合物的方法

Country Status (10)

Country Link
US (1) US5442072A (zh)
EP (1) EP0632025B1 (zh)
JP (1) JP3488930B2 (zh)
KR (1) KR100329100B1 (zh)
CN (1) CN1085662C (zh)
BR (1) BR9402614A (zh)
DE (2) DE4322054A1 (zh)
ES (1) ES2150960T3 (zh)
HU (1) HU213626B (zh)
TW (1) TW253884B (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105622494A (zh) * 2015-10-15 2016-06-01 南京红太阳生物化学有限责任公司 一种2-氯-5-甲基吡啶的制备方法

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR122017023130B1 (pt) 2010-03-12 2018-03-06 Nippon Soda Co., Ltd. Derivado de tetrazoliloxima, métodos de produção de derivados de tetrazoliloxima
CN102603620B (zh) * 2012-01-13 2014-10-29 江苏中邦制药有限公司 一种氯甲基吡啶或其吡啶衍生物盐酸盐的合成方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0508215A1 (de) * 1991-04-06 1992-10-14 Bayer Ag Verfahren zur Herstellung von 2-Chlorpyridinen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3078631B2 (ja) * 1991-12-26 2000-08-21 広栄化学工業株式会社 クロロメチルハロゲノピリジン類の製造方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0508215A1 (de) * 1991-04-06 1992-10-14 Bayer Ag Verfahren zur Herstellung von 2-Chlorpyridinen

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105622494A (zh) * 2015-10-15 2016-06-01 南京红太阳生物化学有限责任公司 一种2-氯-5-甲基吡啶的制备方法
CN105622494B (zh) * 2015-10-15 2019-01-15 南京红太阳生物化学有限责任公司 一种2-氯-5-甲基吡啶的制备方法

Also Published As

Publication number Publication date
EP0632025A1 (de) 1995-01-04
JP3488930B2 (ja) 2004-01-19
JPH0717948A (ja) 1995-01-20
KR950003273A (ko) 1995-02-16
DE4322054A1 (de) 1995-01-12
CN1098405A (zh) 1995-02-08
KR100329100B1 (ko) 2002-08-13
TW253884B (zh) 1995-08-11
HUT67669A (en) 1995-04-28
ES2150960T3 (es) 2000-12-16
HU9401981D0 (en) 1994-09-28
US5442072A (en) 1995-08-15
DE59409558D1 (de) 2000-11-30
HU213626B (en) 1997-08-28
BR9402614A (pt) 1995-04-04
EP0632025B1 (de) 2000-10-25

Similar Documents

Publication Publication Date Title
EP3303454B1 (de) Verfahren zur herstellung von aminosäure-gruppierungen aufweisenden organosiliciumverbindungen
CN1085662C (zh) 制备氯甲基吡啶类化合物的方法
CN1040431C (zh) 2-氯-5-甲基吡啶的制备方法
US8586765B2 (en) Process for the synthesis of 3-amino-3-cyclobuthylmethyl-2-hydroxypropionamide or salts thereof
JP3654306B2 (ja) グリシジルアクリレートまたはグリシジルメタクリレートの製造方法
KR101845624B1 (ko) 고순도 고수율의 디클로로글리옥심의 제조방법
CA2627502A1 (en) Process for production of benzyloxypyrrolidine derivative, and process for production of hydrochloride salt powder of optically active benzyloxypyrrolidine derivative
CN104496737B (zh) 一种合成α‑胺甲酰基氟乙酸酯化合物的方法
CN1114595C (zh) 制备异硫氰酸吡啶基甲酯的方法
IL173773A (en) Method for producing alpha-fluoromalonic acid dialkyl esters
CN1260224C (zh) 噻吩的氯甲基化
US20020013492A1 (en) (Meth)acryloyl-group-containing carbamoyl halides and producion process therefor
US11498917B2 (en) Process for the preparation of lifitegrast
KR100486432B1 (ko) 5-아미노메틸-2-클로로피리딘의 제조 방법
JP3775438B2 (ja) グリシジルメタクリレートまたはグリシジルアクリレートの製造方法
JP4610252B2 (ja) 4−フルオロプロリン誘導体の製造方法
CN1122025C (zh) 制备1-苯基吡唑啉-3-羧酸衍生物的方法
CN1212307C (zh) 一种合成β-氟胺化合物的方法
CN1238349C (zh) L-抗坏血酸多酯物的合成方法
CN101691319A (zh) 一种合成氟代含氮杂环化合物的方法
WO2023048244A1 (ja) テトラフルオロスルファニル基含有アリール化合物の製造方法
CN104557448B (zh) 以炔烃与2,2-二氯-1,1,1-三氟乙烷发生偶联反应制备含氟炔烃的方法
JP3065199B2 (ja) 2−(フルフリルチオ)酢酸誘導体の製造方法
CN108084043A (zh) 一种取代 (3S,4R)/(3R,4S)- Statines化合物及其制备方法
WO2019206695A1 (en) Process for the preparation of 1-(2-methoxymethyl-3-methylphenyl)4h-tetrazolin-5-one

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee